You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Virbac SA - SENTINEL U.S. Rights (Divestiture, in 2020)

Transaction #116402
Investor
1
Sign up to view
Target Company
Virbac SA - SENTINEL U.S. Rights
Life Science · United States
Seller
1
Sign up to view
400 USD
Deal Value
13 May 2020
Announced
Target Company
Company Sector Entity Type Status State Country
Virbac SA - SENTINEL U.S. Rights Life Science Private Active New Jersey (NJ) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Virbac SA - SENTINEL U.S. Rights acquisition deal?
This transaction is an acquisition of Virbac SA - SENTINEL U.S. Rights (Divestiture) in 2020. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Virbac SA - SENTINEL U.S. Rights acquisition happen?
This transaction was announced on 13 May 2020.
What is the deal value of the Virbac SA - SENTINEL U.S. Rights acquisition?
The deal value for this transaction is 400 USD.
Who are the investors in the Virbac SA - SENTINEL U.S. Rights transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Virbac SA - SENTINEL U.S. Rights deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial